Cognition Therapeutics Revenue, Growth & Competitor Profile

Company Profile & Annual Report for Cognition Therapeutics

Access the complete profile.

Cognition Therapeutics Fast Facts

Revenue	$1 - $10 million    See Exact Annual Revenue
Employees	10 - 100Exact Company Size
Primary Industry	5417 Scientific Research & Development Services
Additional NAICS Codes	325412 Pharmaceutical Preparation Manufacturing 541711 Research & Development in Biotechnology
Address	2500 Westchester Avenue Purchase, NY 10577

Note: Revenues for privately held companies are statistical evaluations.


Cognition Therapeutics's Annual Report & Profile shows critical firmographic facts:

• What is the company's size? (Annual sales and employees)
  • Cognition Therapeutics's annual revenues are $1 - $10 million (see exact revenue data)
• What industry is the company in?
  • Cognition Therapeutics is classified as operating in the Scientific Research & Development Services industry, NAICS Code 5417.

Cognition Therapeutics Annual Revenue and Growth Rate

Cognition Therapeutics	Revenue Est. ($ Million)	Growth Rate (%)	# Employees
2025	$1 - $10 million Details in Premium Report
2024
2023
2021
2020
2019

1-Year Growth Rate: 3-Year Growth Rate (CAGR):

Note: Cognition Therapeutics's revenues are gauged from an analysis of company filings.

Cognition Therapeutics's Income Statement (based on Industry Averages)

Cognition Therapeutics P&L	$ Millions
Revenue (Sales)
Cost of Goods Sold
Gross Profit
Operating Expenses
Advertising
Salaries and wages
Other Operating Expenses
Total Operating Expenses
Operating Income
EBITDA
EBIT (Earnings Before Interest and Taxes)
Net Profit

Trademark Applications

Trademark applications show the products and services that Cognition Therapeutics is developing and marketing. Cognition Therapeutics doesn't have any recent trademark applications, indicating Cognition Therapeutics is focusing on its existing business rather than expanding into new products and markets. Trademarks may include brand names, product names, logos and slogans.

Trademark	Date
ELAYTA Pharmaceutical and biological preparations and substances for the treatment of Alzheimer's disease	07/14/2016

See all trademarks and details in the Full Report.

Market Share of Cognition Therapeutics's Largest Competitors

A competitive analysis shows these companies are in the same general field as Cognition Therapeutics, even though they may not compete head-to-head. These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines. The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies. Competitive advantage comes from offering better pricing or superior products/service.

Company	Headquarters	Revenue ($ MM)
LEIDOS	Denver, CO	100
NATIONAL TECHNOLOGY & ENGINEERING SOLUTIONS OF SANDIA	Albuquerque, NM	30
INC RESEARCH	Raleigh, NC	27
RESEARCH FOUNDATION FOR STATE UNIVERSITY OF NEW YORK	Albany, NY	17
FLUOR MARINE PROPULSION	West Mifflin, PA	15
SYNEOS HEALTH	Raleigh, NC	13
ILLUMINA	San Diego, CA	12
UT-BATTELLE	Oak Ridge, TN	11
PRA HOLDINGS	Raleigh, NC	11

Nearby Competitors

These companies are similar in business line and location to Cognition Therapeutics. While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.

Company	Headquarters	Revenue ($ MM)
SB TECHNOLOGY	Tarrytown, NY	100
COGNITION THERAPEUTICS	Purchase, NY	42
ACENT LABORATORIES	Croton On Hudson, NY	42
GNT USA	Tarrytown, NY	29
HYPRES	Elmsford, NY	27
BETTERGY	Peekskill, NY	23

Other Companies at 2500 Westchester Avenue, Purchase NY

Company	Headquarters	Revenue ($ MM)
ATOS	Purchase, NY	100
MAN INVESTMENTS USA HOLDINGS	Purchase, NY	25
UNITED STATES TENNIS ASSOCIATION	Purchase, NY	15
QUORUM FEDERAL CREDIT UNION	Purchase, NY	7
ALPINE WOODS CAPITAL INVESTORS	Purchase, NY	1

Future Competition: Cognition Therapeutics's Fastest Growing Competitors

These companies are in the same general field as Cognition Therapeutics and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.

Company	Revenue ($ MM)